Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon A Jones

Showing results (121-130 of 259) with videos related to

Pageof 26
Sort By:
BMJ Quality & Safety|March 17, 2019
Bending the cost curve: time series analysis of a value transformation programme at an academic medical centreSteven C Chatfield, Frank M Volpicelli, Nicole M Adler, et al.
Nutrients|January 28, 2026
Best Practices for the Nutritional Management of Infantile-Onset Lysosomal Acid Lipase Deficiency: A Case-Based DiscussionFiona J White, Javier de Las Heras, Celia Rodríguez-Borjabad, et al.
American Journal of Medical Genetics. Part A|April 26, 2014
Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey StudyRoberto Giugliani, Christina Lampe, Nathalie Guffon, et al.
European Journal of Medical Genetics|June 9, 2024
Natural history of acid sphingomyelinase deficiency among European patients during childhood and adolescence: A retrospective observational studyEugen Mengel, Maurizio Scarpa, Nathalie Guffon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoformsRachel M McLoughlin, Suzanne M Hurst, Mari A Nowell, et al.
Molecular Genetics and Metabolism|February 3, 2016
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centresArunabha Ghosh, Weston Miller, Paul J Orchard, et al.
Nanoscale|May 11, 2023
Defect-free graphene enhances enzyme delivery to fibroblasts derived from patients with lysosomal storage disordersYingxian Chen, Tooba Taufiq, Niting Zeng, et al.
Orphanet Journal of Rare Diseases|November 17, 2023
Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational studyJoseph Muenzer, Barbara K Burton, Hernan M Amartino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggeringAnne-Catherine Raby, Emmanuel Le Bouder, Chantal Colmont, et al.
Molecular Genetics and Metabolism|January 17, 2026
Safety profile of idursulfase administered at home in patients with mucopolysaccharidosis II enrolled in the Hunter Outcome SurveyBarbara K Burton, Nathalie Guffon, Jane Roberts, et al.
Pageof 26

Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
BMJ Quality & Safety|March 17, 2019
Bending the cost curve: time series analysis of a value transformation programme at an academic medical centreSteven C Chatfield, Frank M Volpicelli, Nicole M Adler, et al.
Nutrients|January 28, 2026
Best Practices for the Nutritional Management of Infantile-Onset Lysosomal Acid Lipase Deficiency: A Case-Based DiscussionFiona J White, Javier de Las Heras, Celia Rodríguez-Borjabad, et al.
American Journal of Medical Genetics. Part A|April 26, 2014
Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey StudyRoberto Giugliani, Christina Lampe, Nathalie Guffon, et al.
European Journal of Medical Genetics|June 9, 2024
Natural history of acid sphingomyelinase deficiency among European patients during childhood and adolescence: A retrospective observational studyEugen Mengel, Maurizio Scarpa, Nathalie Guffon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoformsRachel M McLoughlin, Suzanne M Hurst, Mari A Nowell, et al.
Molecular Genetics and Metabolism|February 3, 2016
Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centresArunabha Ghosh, Weston Miller, Paul J Orchard, et al.
Nanoscale|May 11, 2023
Defect-free graphene enhances enzyme delivery to fibroblasts derived from patients with lysosomal storage disordersYingxian Chen, Tooba Taufiq, Niting Zeng, et al.
Orphanet Journal of Rare Diseases|November 17, 2023
Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational studyJoseph Muenzer, Barbara K Burton, Hernan M Amartino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggeringAnne-Catherine Raby, Emmanuel Le Bouder, Chantal Colmont, et al.
Molecular Genetics and Metabolism|January 17, 2026
Safety profile of idursulfase administered at home in patients with mucopolysaccharidosis II enrolled in the Hunter Outcome SurveyBarbara K Burton, Nathalie Guffon, Jane Roberts, et al.
Pageof 26